Advertisement

Topics

EIB supports development of BiondVax’s universal flu vaccine candidate

05:11 EDT 21 Jun 2017 | Pharmaceutical Business Review

BiondVax Pharmaceuticals, which is developing a universal vaccine for all strains of influenza, has signed an agreement with the European Investment Bank (EIB) for a €20m loan.

Original Article: EIB supports development of BiondVax’s universal flu vaccine candidate

NEXT ARTICLE

More From BioPortfolio on "EIB supports development of BiondVax’s universal flu vaccine candidate"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...